Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 12Genitourinary 12Lymphoid 9Other hematologic neoplasm 7Breast 7Plasma cell 5Gastrointestinal 5CNS 5Sarcoma 4Head & Neck 4Gynecologic 3Endocrine 3NET 2Dermatologic 2Other solid neoplasm 1

Conditions

Solid Tumors 1

Interventions

pralsetinib 1ipatasertib 1inavolisib 1entrectinib 1atezolizumab 1alectinib 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Other solid neoplasm × 30 days × Clear all
NCT04589845 2026-05-08

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Hoffmann-La Roche

Phase 2 Active not recruiting
920 enrolled 1 FDA
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡